Breast cancer is the most prevalent cancer among women worldwide. This thesis will represent the neoadjuvant and adjuvant chemotherapy treatment for triple negative breast cancer and HER2 positive breast cancer.
The thesis includes epidemiology, pathology, molecular subtyping, risk factors, diagnosis, and neoadjuvant and adjuvant chemotherapy treatment for HER2 positive and triple negative breast cancer.